The NIHR Finance Team are based in Barton House, headed by Kathryn Baysdon. The table below outlines their respective areas of responsibility for finance within NIHR infrastructure; find out more by clicking on the bookmarks.
Name

Area of Responsibility

Mark Goulding
Nikson Vazhappilly
  • Biomedical Research Centre (BRC)
  • Experimental Cancer Medicine (ECM)
  • Health Technology Cooperative (HTC)
  • Genomic Medicine Centre (GMC)
  • Clinical Trials Unit (CTU)
  • R&D Department
  • Euro Grants
Gemma Turner

    ​​​​​

Biomedical Research Centre (BRC): Contact Nikson Vazhappilly

Formed through partnerships between England’s leading NHS organisations and universities, 20 NIHR Biomedical Research Centres (BRCs) conduct translational research to transform scientific breakthroughs into life-saving treatments for patients.

Staffed by expert investigators and clinicians, NIHR BRCs are leaders in translating lab-based discoveries into new cutting-edge treatments, technologies, diagnostics and other interventions in clinical settings. Their aims are to:

  • drive innovation in the prevention, diagnosis and treatment of ill-health
  • translate advances in biomedical research into benefits for patients
  • provide a key component of the NHS contribution to our nation’s international competitiveness by making the best Centres even better

The substantial levels of sustained funding that NIHR BRCs receive creates an environment in which scientific endeavour can thrive, attract the foremost talent and produce world-class outputs, hence contributing to the nation’s international competitiveness as a major component of our knowledge economy.

Cambridge BRC is in its third 5-year funding period. The original agreement ran for 2007-2012 and was subsequently renewed for the 2012-17 and 2017-22 5-year periods. The current funding agreement runs for the period 01/04/17 – 31/03/22.

Clinical Research Network (CRN): Contact Gemma Turner

The CRN makes it possible for patients and health professionals across England to participate in clinical research studies within the NHS. The CRN provides the infrastructure that allows high-quality clinical research funded by charities, research funders and the life-sciences industry to be undertaken throughout the NHS.

The CRN meets the costs of NHS staff that support research and provides specialist training so that patients can be confident that research is being delivered by trained, experienced front-line NHS staff.

It also meets the costs of using NHS facilities, such as scanners and x-rays that are needed in the course of a study, so that research is not subsidised with funding that has been provided for patient care.

The CRN provided practical help in identifying and recruiting patients for Portfolio studies, so that researchers can be confident of completing the study on time and as planned.

Research Capability Funding (RCF): Contact Mark Goulding

Research Capability Funding is allocated to research-active NHS organisations in proportion to the total amount of other NIHR income received by that organisation, and on the number of NIHR Senior Investigators associated with the organisation. Its purpose is to:

  • help research-active NHS organisations to act flexibly and strategically to maintain research capacity and capability
  • support the appointment, development and retention of key staff undertaking or supporting people and patient-based based research
  • contribute towards costs of hosting NIHR-funded or ‘adopted’ research that are not currently fully covered across NIHR’s programmes, and that are not met in other ways

Cambridge Clinical Research Centre (CCRC): Contact Gemma Turner

Also known as Addenbrooke's Clinical Research Centre (ACRC), the CCRC consists of the NIHR/Wellcome Trust Clinical Research Facility (CRF) and a Clinical Investigation Ward (CIW), providing a safe, well-equipped and professionally staffed research facility. 

Specialising in supporting researchers, especially those with experimental medicine projects and early phase clinical trials, early discussion with investigators is welcomed. It currently supports over 220 studies, the majority of which involve either medium- or high-intensity interventions in adults and children. 

Click here for where to find us and contact details.